文献速递流行病学与生物统计基础与转化研究

磷酸二酯酶5抑制与男性生育力、性行为及主观幸福感的孟德尔随机化研究

A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation study.
PubMed 文献 · BMJ · 2023-12-12

该研究采用两样本顺式孟德尔随机化设计,利用国际血压联盟(n=757601)和英国生物银行(n=211840)的遗传关联汇总数据,以舒张压降低作为磷酸二酯酶5(PDE5)抑制的替代生物标志物。结果显示,遗传代理的PDE5抑制与男性多生育0.28个子女相关(95%CI 0.16至0.39,错误发现率校正P<0.001),该关联在女性中未观察到;未见与性伴侣数量、从未发生性交概率或主观幸福感相关。

要点

  • 遗传代理的PDE5抑制与男性多生育0.28个子女相关(95%CI 0.16至0.39,错误发现率校正P<0.001)。
  • 该关联在女性参与者中未观察到。
  • 未见与性伴侣数量、从未发生性交概率或主观幸福感相关。

核心结论

  • 研究结果为PDE5抑制可能增加男性生育子女数量提供了遗传学支持。
  • 女性中缺乏该关联支持持续且坚挺的阴茎勃起倾向增加作为潜在机制,但需进一步研究确认。
  • 这些发现不应促使 indiscriminate 使用PDE5抑制剂,因其也可能有害不良影响。

研究设计与样本

  • 两样本顺式孟德尔随机化研究。
  • 从国际血压联盟(n=757601)获取遗传关联汇总数据以估计PDE5抑制(使用舒张压降低作为替代生物标志物)。
  • 从英国生物银行(n=211840)获取男性参与者的生育力、性行为和主观幸福感结局数据。

主要发现

  • 遗传代理的PDE5抑制与男性多生育0.28个子女相关(95%CI 0.16至0.39,错误发现率校正P<0.001)。
  • 该关联在女性参与者中未观察到。
  • 未发现遗传代理的PDE5抑制与男性性伴侣数量、从未发生性交概率或自我报告幸福感相关的证据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需进一步研究确认该发现。
  • 这些发现不应促使 indiscriminate 使用PDE5抑制剂,因其也可能有害不良影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the association of genetically proxied (using a surrogate biomarker) inhibition of phosphodiesterase 5 (PDE5), an established drug target for erectile dysfunction, with fertility, sexual behaviour, and subjective wellbeing. DESIGN: Two sample cis-mendelian randomisation study. SETTING: Summary data on genetic associations obtained from the International Consortium for Blood Pressure and UK Biobank. PARTICIPANTS: Individuals of European ancestry from the International Consortium for Blood Pressure (n=757 601) for estimating PDE5 inhibition (using the surrogate biomarker of diastolic blood pressure reduction), and UK Biobank (n=211 840) for estimating the fertility, sexual behaviour, and subjective wellbeing outcomes in male participants. INTERVENTION: Genetically proxied PDE5 inhibition. MAIN OUTCOME MEASURES: Number of children fathered, number of sexual partners, probability of never having had sexual intercourse, and subjective wellbeing. RESULTS: Genetically proxied PDE5 inhibition was associated with male participants having 0.28 (95% confidence interval 0.16 to 0.39) more children (false discovery rate corrected P<0.001). This association was not identified in female participants. No evidence was found of an association between genetically proxied PDE5 inhibition and number of sexual partners, probability of never having had sexual intercourse, or self-reported wellbeing in male participants. CONCLUSIONS: The findings of this study provide genetic support for PDE5 inhibition potentially increasing the number of children fathered by male individuals. Absence of this association in female participants supports increased propensity for sustained and robust penile erections as a potential underlying mechanism. Further studies are required to confirm this, however, and these findings should not promote indiscriminate use of PDE5 inhibitors, which can also have harmful adverse effects.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Woolf B, Rajasundaram S, Cronjé HT, et al. A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation study. BMJ. 2023. PMID: 38086555. doi:10.1136/bmj-2023-076197

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。